Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Context Therapeutics Inc. (CNTX) Debt to Capital Ratio data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-36.12M |
|
-- |
|
-- |
|
$39.70M |
|
$-39.70M |
|
$3.58M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-39.70M |
|
$-39.69M |
|
95.19M |
|
95.19M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$68.35M |
|
$0.03M |
|
$0.14M |
|
$68.49M |
|
$8.02M |
|
-- |
|
-- |
|
$8.02M |
|
$60.47M |
|
$60.47M |
|
$60.47M |
|
91.88M |
|
| Cash Flow Statement Financials | |
$-26.39M |
|
$-2.03M |
|
$-0.02M |
|
$94.43M |
|
$66.00M |
|
$-28.43M |
|
$1.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.52 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.73% |
|
-59.73% |
|
-52.74% |
|
-59.73% |
|
$0.66 |
|
$-0.28 |
|
$-0.28 |
|